Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017 by Colum O'connor, Yale University
Heart study finds faulty link between biomarkers and clinical outcomes
Credit: stock.adobe.com

Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to a recent study by Yale School of Medicine researchers in JAMA.

Biomarkers generally refer to diseases, symptoms, and signs during clinical trials that are associated with other, more complicated diseases and symptoms (clinical outcomes).

In the Yale study, lead author and internal medicine resident at Yale School of Medicine Dr. Behnood Bikdeli and his colleagues examined the potential disconnect between biomarkers and clinical outcomes by screening prior publications in the field of . They found that although the surrogate endpoint trials published in the highest-impact journals frequently demonstrated high effectiveness of the tested drug, less than one third of them had a clinical outcomes trial of the drug for the same purpose published.

Additionally, when there was a subsequent trial, approximately half failed to validate the positive impact of the drug on the . Bikdeli notes that while the new findings only apply to the field of cardiovascular medicine, doctors and researchers in other fields, such as oncology, hold similar reservations about using biomarkers to approve .

Explore further: Yale researchers see decline in hospitalizations for serious heart infection

More information: Behnood Bikdeli et al. Two Decades of Cardiovascular Trials With Primary Surrogate Endpoints: 1990–2011, Journal of the American Heart Association (2017). DOI: 10.1161/JAHA.116.005285

Related Stories

Yale researchers see decline in hospitalizations for serious heart infection

September 16, 2013
Hospitalizations for endocarditis, a deadly heart infection that disproportionately affects older heart patients, have declined in recent years despite recommendations for limited use of antibiotics to prevent the illness. ...

All water pills not equally effective against heart failure

April 1, 2013
Loop diuretics, more commonly known as water pills, are the most widely prescribed heart failure medications, but few studies had extensively compared their effectiveness until Yale School of Medicine researchers examined ...

Study finds patterns of biomarkers predict how well people age, risks of age-related disease

January 6, 2017
Levels of specific biomarkers, or chemicals found in the blood, can be combined to produce patterns that signify how well a person is aging and his or risk for future aging-related diseases, according to a new study by researchers ...

Heart risks of glucose-lowering drugs being overlooked in clinical trials

March 12, 2014
Why is heart failure not more rigorously assessed in clinical trials of antidiabetes drugs? In a Personal View, published in The Lancet Diabetes & Endocrinology journal, Professor John McMurray of The University of Glasgow ...

Personalized medicine leads to better outcomes for patients with cancer

June 6, 2016
In a meta-analysis of hundreds of clinical trials involving thousands of patients, researchers at University of California San Diego School of Medicine report that therapeutic approaches using precision medicine, which emphasizes ...

Biological markers increase clinical trial success rate of new breast cancer drugs

October 1, 2012
Using biological markers—genetic characteristics that are associated with some patients with breast cancer—can increase the success rate of clinical trials for breast cancer drugs by almost 50 per cent, says new research ...

Recommended for you

Stroke drug demonstrates safety in clinical trial

February 20, 2018
A preliminary Phase 2 clinical trial has demonstrated that patients with acute ischemic stroke, the most common type of stroke, can safely tolerate high doses of 3K3A-APC, a promising anti-stroke drug invented at The Scripps ...

Can your cardiac device be hacked?

February 20, 2018
Medical devices, including cardiovascular implantable electronic devices could be at risk for hacking. In a paper publishing online today in the Journal of the American College of Cardiology, the American College of Cardiology's ...

Women once considered low risk for heart disease show evidence of previous heart attack scars

February 20, 2018
Women who complain about chest pain often are reassured by their doctors that there is no reason to worry because their angiograms show that the women don't have blockages in the major heart arteries, a primary cause of heart ...

Number of obese years not—just obesity—a distinct risk factor for heart damage

February 20, 2018
In an analysis of clinical data collected on more than 9,000 people, Johns Hopkins researchers have shown that the number of years spent overweight or obese appear to "add up" to a distinct risk factor that makes those with ...

Heart attack symptoms often misinterpreted in younger women

February 20, 2018
Young women who report heart attack symptoms are more likely to have them dismissed by their providers as not heart related, a new study led by the Yale School of Public Health (YSPH) finds.

A drug long used to treat gout may help adult heart failure patients

February 20, 2018
Researchers at the University of Cincinnati (UC) College of Medicine have shown that probenecid, a drug long used to treat gout, may be able to improve heart function in adult patients who experience heart failure.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.